|
|
1.
|
Effect of the BET Protein Inhibitor, RVX-208, on Progression of Coronary Atherosclerosis: Results of the Phase 2b, Randomized, Double-Blind, Multicenter, ASSURE Trial. MedStar authors:
Year: 2016
Citation: - American Journal of Cardiovascular Drugs. 16(1):55-65, 2016 Feb.
Institution: - MedStar Health Research Institute
Medline publication type:
- Clinical Trial, Phase II
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
All authors: - Ballantyne CM, Barter PJ, Borgman M, Brewer HB, Herrman JP, Hu B, Kastelein JJ, Kataoka Y, Merkely B, Nicholls SJ, Nissen SE, Puri R, Uno K, Wolski K
|
|
|
2.
|
Intravascular ultrasound analysis to determine the relationship between high-density lipoprotein cholesterol and lesion characteristics in patients with coronary artery disease. MedStar authors:
- Brewer, H Bryan
- Chen, Fang
- Kitabata, Hironori
- Loh, Joshua P
- Magalhaes, Marco A
- Omar, Al Fazir
- Pendyala, Lakshmana K
- Pichard, Augusto D
- Torguson, Rebecca
- Waksman, Ron
Year: 2014
Citation: - Journal of Interventional Cardiology. 27(3):325-33, 2014 Jun.
Institution:
- MedStar Health Research Institute
- MedStar Heart & Vascular Institute
Medline publication type:
- Journal Article
- Randomized Controlled Trial
All authors: - Brewer HB Jr, Chen F, Kitabata H, Loh JP, Magalhaes MA, Omar A, Pendyala LK, Pichard AD, Torguson R, Waksman R
|
